What this means
Researchers tracked adults who had one combined non-surgical brow treatment and measured eyebrow height over a year. The study did not compare this treatment with any other option, so it cannot show it works better.
Plain-English summary written by an AI model from the registry listing.
- Status
- Completed
- Who can join
- Ages 35–65 · 36 adults
- Where
- 1 site
The science
- Registered title
- Single-Session Microfocused Ultrasound, AbobotulinumtoxinA and Temporal Hyaluronic Acid Filler for Non-Surgical Brow Lifting
- Trial ID
- NCT07894822 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Brow Ptosis, Skin Aging, Facial Aging
- What is tested
- Microfocused ultrasound with visualization, AbobotulinumtoxinA, Hyaluronic acid filler
- Sponsor
- Estelab Clinic
- Ages
- 35 Years to 65 Years
- Dates
- First posted Oct 26, 2026 · updated Oct 26, 2026
Registry summary
This observational study describes the results of a routine aesthetic treatment for mild to moderate eyebrow drooping (brow ptosis). Thirty-six adults who came to Klinika Estelab (Moscow) asking for rejuvenation of the upper face received, as part of their usual care, one combined treatment session: microfocused ultrasound with visualization (Ultherapy), abobotulinumtoxinA (Dysport) injections, and hyaluronic acid filler in the temples, with a routine toxin touch-up after 2 weeks. The investigators did not assign any treatment; they only added standardized assessments. Eyebrow height was measured on standardized photographs before treatment, immediately after treatment, and at 1, 3, 6, and 12 months. Aesthetic improvement, patient satisfaction, procedural pain, and side effects were also recorded.
Sites (1)
- Klinika Estelab LLC, Moscow, Moscow, Russia
Related treatments
Hyaluronic acid fillers · Botox and other wrinkle-relaxing injections · Ultrasound skin lifting (Ultherapy)